Furthermore, opiorphin may indirectly contribute to pain perception in BMS patients by altering the level of the pro‐inflammatory peptide of substance‐p in saliva (Boucher et al. 2017, Ozdogan et al. 2019). This evidence concerns the gene OPRPN and burning mouth syndrome.